On Monday, November 16, 2020, the Company, Gilead Sciences, Inc., GILD stock construct a change of 0.83 percent (Gain) in a total of its share price and having its trading value $61.09, which belongs to Healthcare sector and Drug Manufacturers – General industry. The company?s Market capitalization was $75.81B with the total Outstanding Shares of 1.26B.
P/S, P/E, P/B & P/C values of (NASDAQ: GILD):
Gilead Sciences, Inc. institutional ownership is standing at 82 percent, while insider ownership is 0.4 percent. As of now, GILD has a P/S, P/E and, P/B values of 3.28, 63.5, and 4.39 respectively. Its P/Cash is valued at 3.16.
The stock SMA50 is now at -1.78 percent. In looking, the SMA 200 we see that the stock has seen a -13.68 percent. The Company?s net profit margin for the 12 months at 5.5 percent. Comparatively, the gazes have a Gross margin of 79 percent.
Looking into the profitability ratios of GILD stock, an investor will find its ROE, ROA, ROI standing at 6.3 percent, 2.1 percent and, 9.5 percent, respectively.
A beta factor is used to measure the volatility of the stock. The stock remaining at 2.76 percent volatile for the week and 2.44 percent for the month.
Gross / Operating Margins of GILD:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 79 percent & Operating Margin seen at 10.9 percent.
Target Price informs the inves tors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Gilead Sciences, Inc. recorded it at $74.04.
Historical Performance In The News:
Taking a look at the performance of Gilead Sciences, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 3.45 percent, resulting in a performance for the month at -1.47 percent.
Therefore, the stated figure displays a quarterly performance of -11.54 percent, bringing six-month performance to -15.55 percent and year to date performance of -5.99 percent. As of now, Gilead Sciences, Inc. has a P/S, P/E and, P/B values of 3.28, 63.5, and 4.39 respectively. Its P/Cash is valued at 3.16.
Earnings per Share Details of Gilead Sciences, Inc.:
The EPS of GILD is strolling at 0.96, measuring its EPS growth this year at 1.1 percent. As a result, the company has an EPS growth of 1.18 percent for the approaching year.